Indefinite Delivery Contract SPE2DR25D9208

The Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Illinois. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.

The IDC covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to DoD healthcare sites. The IDC was awarded as part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V solicitation, which aims to establish multiple regional prime vendor contracts valued at an estimated $30.3 billion to support pharmaceutical requirements for the DoD, Coast Guard, and other government agencies.